Target intelligence / Profile preview

Cytochrome P450 family 27 subfamily C member 1 (CYP27C1)

Target
CYP27C1
Molecular classification
Enzyme, Cytochrome P450, Oxidoreductase
01

Overview

Cytochrome P450 family 27 subfamily C member 1 (CYP27C1) is a member of the cytochrome P450 superfamily of monooxygenase enzymes, primarily functioning as an all-trans-retinol 3,4-desaturase. It catalyzes the conversion of vitamin A1 (all-trans-retinol) to vitamin A2 (all-trans-3,4-dehydroretinal), playing a critical role in retinoid metabolism. CYP27C1 is expressed in human skin epidermis and is notable among mammalian P450 enzymes for mediating a desaturation reaction rather than typical hydroxylation. It also has minor hydroxylation activity. This enzyme contributes to drug metabolism, lipid biosynthesis, and may negatively regulate lung cancer cell proliferation through IGF-1R/Akt/p53 signaling. Clinical relevance includes associations with disorders of vitamin A deficiency and potential roles in cancer biology. CYP27C1 can also metabolize certain chemotherapeutics (e.g., vinorelbine) and is inhibited by drugs such as ketoconazole in laboratory assays[1][3][5].

Other names
all-trans-retinol 3,4-desaturaseP450 27C1
02

Mechanism of action

Substrate oxidation/desaturation (conversion of all-trans-retinol to all-trans-3,4-dehydroretinol through desaturation); drug metabolism via retinoid modification

03

Biological functions

Vitamin A metabolismLipid metabolismDrug metabolismRetinoid desaturationRegulation of cell proliferation
04

Disease associations

CancerKeratomalaciaAnemia (specifically X-linked sideroblastic anemia with ataxia)Other diseases related to vitamin A and retinoid metabolism
05

Safety considerations

Potential impact on vitamin A metabolism and retinoid homeostasisPossible role in regulating proliferation in lung cancer and, therefore, implications for cancer therapy
06

Interacting drugs

vinorelbine (potential as a substrate)

1 more in the full profile.

Beyond the preview

Go deeper on Cytochrome P450 family 27 subfamily C member 1 (CYP27C1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome P450 family 27 subfamily C member 1 (CYP27C1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call